Author details

Full Name

John D Carpten

Affiliation

ORCID

Career Start Year

1994

Papers

224

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37292833	Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry.	medRxiv	2023
36283023	Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer.	Cancer Research	2023
37945903	Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.	Nat Genet	2023
38001255	Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent.		2023
37995179	Alveolar type I cells can give rise to KRAS-induced lung adenocarcinoma.		2023
37894280	The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors.	Cancers (Basel)	2023
37703814	Florida-California Cancer Research, Education and Engagement (CaRE<sup>2</sup>) Health Equity Center: Structure, Innovations, and Initial Outcomes.	Cancer Control	2023
36872133	Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.	Eur Urol	2023
36623238	Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations.	JCO Precis Oncol	2023
37311464	Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.	Am J Hum Genet	2023
37104368	Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma.	PLoS One	2023
36791345	Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network.	Cancer Epidemiol Biomarkers Prev	2023
35106045	Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials.	Ethnicity and Disease	2022
35522911	Strategies to Increase Participation of African Populations in Clinical Trials.	American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting	2022
35384527	Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer.	Cancer Causes and Control	2022
36008758	Results and lessons from dual extraction of DNA and RNA from formalin-fixed paraffin-embedded breast tumor tissues for a large Cancer epidemiologic study.	BMC Genomics	2022
36121736	African Ancestry-Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent.	Cancer Discov	2022
35031163	A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.	Eur Urol	2022
34437759	Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.	Mol Oncol	2022
34635800	Correction: Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients.	Oncogene	2021
32430639	Developing a Novel Framework for an Undergraduate Cancer Research Education and Engagement Program for Underrepresented Minority Students: the Florida-California CaRE Research Education Core (REC) Training Program.	Journal of Cancer Education	2021
33473200	Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Nat Genet	2021
33576900	Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry.	Breast Cancer Res Treat	2021
33826920	Applicability of spatial transcriptional profiling to cancer research.	Mol Cell	2021
33826614	Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.	PLoS One	2021
34188191	Making cancer research more inclusive.	Nat Rev Cancer	2021
33713608	Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry.	Am J Hum Genet	2021
32800727	Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer.	Eur Urol	2021
33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Nat Genet	2021
34573384	Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas.	Genes (Basel)	2021
34554099	Analysis of Population Differences in Digital Conversations About Cancer Clinical Trials: Advanced Data Mining and Extraction Study.	JMIR Cancer	2021
34433909	Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients.	Oncogene	2021
32743548	Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression.	Neurooncol Adv	2020
32409115	A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.	Eur Urol	2020
31935283	A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.	Blood Adv	2020
32037533	Cancer transcriptomic profiling from rapidly enriched circulating tumor cells.	Int J Cancer	2020
33141623	Patterns of Early-Onset Colorectal Cancer Among Nigerians and African Americans.	JCO Glob Oncol	2020
32587328	Single-cell sequencing of genomic DNA resolves sub-clonal heterogeneity in a melanoma cell line.	Commun Biol	2020
33030342	Development of a Potent and Specific FGFR4 Inhibitor for the Treatment of Hepatocellular Carcinoma.	Journal of Medicinal Chemistry	2020
31479341	Pathology Services in Nigeria: Cross-Sectional Survey Results From Three Cancer Consortia.	Journal of global oncology	2019
30218760	Histological Validation of 11Carbon-Acetate Positron Emission Tomography/Computerized Tomography in Detecting Lymph Node Metastases in Prostate Cancer.	J Urol	2019
30264293	E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.	Invest New Drugs	2019
30987182	Comparing the Utility of Mitochondrial and Nuclear DNA to Adjust for Genetic Ancestry in Association Studies.	Cells	2019
30702443	Multiparametric liquid biopsy analysis in metastatic prostate cancer.	JCI Insight	2019
30728399	Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer.	Scientific Reports	2019
29365035	Integrating the Genetics of Race and Ethnicity Into Cancer Research: Trailing Jane and John Q. Public.	JAMA Surgery	2018
30304372	Mitochondrial biology and prostate cancer ethnic disparity.	Carcinogenesis	2018
30239619	Lack of APC somatic mutation is associated with early-onset colorectal cancer in African Americans.	Carcinogenesis	2018
30524885	Profiling targetable immune checkpoints in osteosarcoma.	Oncoimmunology	2018
29610397	The era of precision oncogenomics.	Cold Spring Harb Mol Case Stud	2018